2019, Volume 5, Issue 5
Engineering >> 2019, Volume 5, Issue 5 doi: 10.1016/j.eng.2019.07.012
Understanding the Removal and Fate of Selected Drugs of Abuse in Sludge and Biosolids from Australian Wastewater Treatment Operations
a Natural and Built Environments Research Centre, School of Natural and Built Environments, University of South Australia, Mawson
Lakes, SA 5095, Australia
b School of Pharmacy and Medical Science, University of South Australia, North Terrace, SA 5000, Australia
c Division of Information Technology, Engineering and the Environment, University of South Australia, Mawson Lakes, SA 5095,
Australia
d Australian Water Quality Center, Adelaide, SA 5000, Australia
e Future Industries Institute, University of South Australia, Mawson Lakes, SA 5095, Australia
Next Previous
Abstract
Illicit and pharmaceutical drugs are considered to be emerging contaminants of concern, and much research effort has gone into assessing their occurrence in wastewater. However, little information exists on their presence in treated sludge or biosolids. In this study, we examined sludge and biosolids from a large metropolitan wastewater treatment plant (WWTP) in Australia to determine the occurrence of five drugs of abuse, including benzoylecgonine as indicator of cocaine consumption, methamphetamine and 3,4-methylenedioxy methamphetamine (MDMA) as representative illicit stimulants, and codeine and morphine as pharmaceuticals with potential environmental risk. The samples were solid-phase extracted and analyzed by liquid chromatography-tandem mass spectrometry (LCMS/MS). Benzoylecgonine and MDMA were present in raw sludge but were notably degraded during solids treatment processes, and were not detected in the dewatered sludge (after treatment) or in biosolids. Methamphetamine, codeine, and morphine were detected in all biosolids samples at mean concentrations of 20–50 μg·kg−1. The presence of these three drugs in biosolids shows that these compounds are relatively stable in the solids and in soil, and can persist in biosolids for at least several years. A simple environmental risk assessment based on
estimated risk quotients (RQs) for these compounds indicated that the potential environmental risks associated with the land application of biosolids are very low at typical Australian biosolids application rates.
Keywords
Anaerobic digestion ; Biosolids ; Contamination ; Methamphetamine ; Sorption
Figures
Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
References
[ 1 ] Baker DR, Kasprzyk-Hordern B. Critical evaluation of methodology commonly used in sample collection, storage and preparation for the analysis of pharmaceuticals and illicit drugs in surface water and wastewater by solid phase extraction and liquid chromatography-mass spectrometry. J Chromatogr A 2011;1218(44):8036–59. link1
[ 2 ] Castiglioni S, Zuccato E, Chiabrando C, Fanelli R, Bagnati R. Mass spectrometric analysis of illicit drugs in wastewater and surface water. Mass Spectrom Rev 2008;27(4):378–94. link1
[ 3 ] Hernández F, Ibáñez M, Botero-Coy AM, Bade R, Bustos-López MC, Rincón J, et al. LC-QTOF MS screening of more than 1000 licit and illicit drugs and their metabolites in wastewater and surface waters from the area of Bogotá, Colombia. Anal Bioanal Chem 2015;407(21):6405–16. link1
[ 4 ] Li K, Du P, Xu Z, Gao T, Li X. Occurrence of illicit drugs in surface waters in China. Environ Pollut 2016;213:395–402. link1
[ 5 ] Huerta-Fontela M, Pineda O, Ventura F, Galceran MT. New chlorinated amphetamine-type-stimulants disinfection-by-products formed during drinking water treatment. Water Res 2012;46(10):3304–14. link1
[ 6 ] Szymonik A, Lach J, Malin´ ska K. Fate and removal of pharmaceuticals and illegal drugs present in drinking water and wastewater. Ecol Chem Eng S 2017;24(1):65–85. link1
[ 7 ] Huerta-Fontela M, Galceran MT, Ventura F. Stimulatory drugs of abuse in surface waters and their removal in a conventional drinking water treatment plant. Environ Sci Technol 2008;42(18):6809–16. link1
[ 8 ] Rodayan A, Afana S, Segura PA, Sultana T, Metcalfe CD, Yargeau V. Linking drugs of abuse in wastewater to contamination of surface and drinking water. Environ Toxicol Chem 2016;35(4):843–9. link1
[ 9 ] Benotti MJ, Trenholm RA, Vanderford BJ, Holady JC, Stanford BD, Snyder SA. Pharmaceuticals and endocrine disrupting compounds in US drinking water. Environ Sci Technol 2009;43(3):597–603. link1
[10] Jurado A, Mastroianni N, Vàzquez-Suñé E, Carrera J, Tubau I, Pujades E, et al. Drugs of abuse in urban groundwater. A case study: Barcelona. Sci Total Environ 2012;424:280–8. link1
[11] Karnjanapiboonwong A, Suski JG, Shah A, Cai Q, Morse AN, Anderson T. Occurrence of PPCPs at a wastewater treatment plant and in soil and groundwater at a land application site. Water Air Soil Pollut 2011;216(1–4):257–73. link1
[12] Geissen V, Mol H, Klumpp E, Umlauf G, Nadal M, Van der Ploeg M, et al. Emerging pollutants in the environment: a challenge for water resource management. Int Soil Water Conserv Res 2015;3(1):57–65. link1
[13] Liao PH, Yang WK, Yang CH, Lin CH, Hwang CC, Chen PJ. Illicit drug ketamine induces adverse effects from behavioral alterations and oxidative stress to p53-regulated apoptosis in medaka fish under environmentally relevant exposures. Environ Pollut 2018;237:1062–71. link1
[14] Ondarza PM, Haddad SP, Avigliano E, Miglioranza KSB, Brooks BW. Pharmaceuticals, illicit drugs and their metabolites in fish from Argentina: implications for protected areas influenced by urbanization. Sci Total Environ 2019;649:1029–37. link1
[15] Ebele AJ, Abou-Elwafa Abdallah M, Harrad S. Pharmaceuticals and personal care products (PPCPs) in the freshwater aquatic environment. Emerging Contam 2017;3(1):1–16. link1
[16] Verlicchi P, Zambello E. Pharmaceuticals and personal care products in untreated and treated sewage sludge: occurrence and environmental risk in the case of application on soil—a critical review. Sci Total Environ 2015;538:750–67. link1
[17] Mastroianni N, Postigo C, De Alda ML, Barcelo D. Illicit and abused drugs in sewage sludge: method optimization and occurrence. J Chromatogr A 2013;1322:29–37. link1
[18] Díaz-Cruz MS, García-Galán MJ, Guerra P, Jelic A, Postigo C, Eljarrat E, et al. Analysis of selected emerging contaminants in sewage sludge. TrAC Trends Anal Chem 2009;28(11):1263–75. link1
[19] Petrovic M, De Alda MJL, Diaz-Cruz S, Postigo C, Radjenovic J, Gros M, et al. Fate and removal of pharmaceuticals and illicit drugs in conventional and membrane bioreactor wastewater treatment plants and by riverbank filtration. Philos Trans A Math Phys Eng Sci 1904;2009(367):3979–4003. link1
[20] Kaleta A, Ferdig M, Buchberger W. Semiquantitative determination of residues of amphetamine in sewage sludge samples. J Sep Sci 2006;29(11):1662–6. link1
[21] Jones-Lepp TL, Stevens R. Pharmaceuticals and personal care products in biosolids/sewage sludge: the interface between analytical chemistry and regulation. Anal Bioanal Chem 2007;387(4):1173–83. link1
[22] Ivanová L, Mackul’ak T, Grabic R, Golovko O, Koba O, Stanˇová AV, et al. Pharmaceuticals and illicit drugs—a new threat to the application of sewage sludge in agriculture. Sci Total Environ 2018;634:606–15. link1
[23] Kinney CA, Furlong ET, Zaugg SD, Burkhardt MR, Werner SL, Cahill JD, et al. Survey of organic wastewater contaminants in biosolids destined for land application. Environ Sci Technol 2006;40(23):7207–15. link1
[24] Zhang W, Alvarez-Gaitan JP, Dastyar W, Saint CP, Zhao M, Short MD. Valueadded products derived from waste activated sludge: a biorefinery perspective. Water 2018;10(5):545. link1
[25] Spinosa L. Wastewater sludge: a global overview of the current status and future prospects. In: Water intelligence online. London: IWA Publishing; 2011.
[26] Australian and New Zealand Biosolids Partnership [Internet]. Australian Biosolids Statistics—2017. St Leonards: Australian Water Association [cited 2019 Apr 9]. Available from: https://www.biosolids.com.au/guidelines/ australian-biosolids-statistics/. link1
[27] Clarke BO, Smith SR. Review of ‘emerging’ organic contaminants in biosolids and assessment of international research priorities for the agricultural use of biosolids. Environ Int 2011;37(1):226–47. link1
[28] Wijesekara H, Bolan NS, Thangavel R, Seshadri B, Surapaneni A, Saint C, et al. The impact of biosolids application on organic carbon and carbon dioxide fluxes in soil. Chemosphere 2017;189:565–73. link1
[29] Xia K, Bhandari A, Das K, Pillar G. Occurrence and fate of pharmaceuticals and personal care products (PPCPs) in biosolids. J Environ Qual 2005;34 (1):91–104. link1
[30] Gibson R, Wang MJ, Padgett E, Beck AJ. Analysis of 4-nonylphenols, phthalates, and polychlorinated biphenyls in soils and biosolids. Chemosphere 2005;61 (9):1336–44. link1
[31] Leiva C, Ahumada I, Sepúlveda B, Richter P. Polychlorinated biphenyl behavior in soils amended with biosolids. Chemosphere 2010;79(3):273–7. link1
[32] Andrade NA, McConnell LL, Torrents A, Ramirez M. Persistence of polybrominated diphenyl ethers in agricultural soils after biosolids applications. J Agric Food Chem 2010;58(5):3077–84. link1
[33] Wang H, Lin K, Hou Z, Richardson B, Gan J. Sorption of the herbicide terbuthylazine in two New Zealand forest soils amended with biosolids and biochars. J Soils Sediments 2010;10(2):283–9. link1
[34] Parolini M, Magni S, Castiglioni S, Zuccato E, Binelli A. Realistic mixture of illicit drugs impaired the oxidative status of the zebra mussel (Dreissena polymorpha). Chemosphere 2015;128:96–102. link1
[35] Rogers HR. Sources, behaviour and fate of organic contaminants during sewage treatment and in sewage sludges. Sci Total Environ 1996;185(1–3):3–26. link1
[36] Schäfer AI, Akanyeti I, Semião AJC. Micropollutant sorption to membrane polymers: a review of mechanisms for estrogens. Adv Colloid Interface Sci 2011;164(1–2):100–17. link1
[37] Herklotz PA, Gurung P, Vanden Heuvel B, Kinney CA. Uptake of human pharmaceuticals by plants grown under hydroponic conditions. Chemosphere 2010;78(11):1416–21. link1
[38] Jones-Lepp TL, Sanchez CA, Moy T, Kazemi R. Method development and application to determine potential plant uptake of antibiotics and other drugs in irrigated crop production systems. J Agric Food Chem 2010;58(22):11568–73. link1
[39] Dolliver H, Kumar K, Gupta S. Sulfamethazine uptake by plants from manureamended soil. J Environ Quality 2007;36(4):1224–30. link1
[40] Yadav MK, Short MD, Gerber C, Van den Akker B, Aryal R, Saint CP. Occurrence, removal and environmental risk of markers of five drugs of abuse in urban wastewater systems in South Australia. Environ Sci Pollut Res Int. Epub 2018 Jun 9. link1
[41] Devault DA, Néfau T, Levi Y, Karolak S. The removal of illicit drugs and morphine in two waste water treatment plants (WWTPs) under tropical conditions. Environ Sci Pollut Res Int 2017;24(33):25645–55. link1
[42] Skees AJ, Foppe KS, Loganathan B, Subedi B. Contamination profiles, mass loadings, and sewage epidemiology of neuropsychiatric and illicit drugs in wastewater and river waters from a community in the midwestern United States. Sci Total Environ 2018;631–632:1457–64. link1
[43] Govindarasu P. Illicit drugs—environmental occurrence, fate and toxicity [dissertation]. New Castle: The University of New Castle; 2016. link1
[44] McClellan K, Halden RU. Pharmaceuticals and personal care products in archived U.S. biosolids from the 2001 EPA National Sewage Sludge Survey. Water Res 2010;44(2):658–68. link1
[45] Higgins CP, Sharp JO, Sepulvado JG, Littrell B, O’Connor G, Snyder E, et al. Trace organic chemicals in biosolids-amended soils: state-of-the-science review. Final report. Denver: Water Environment Research Foundation. London: IWA Publishing; 2010. link1
[46] Guerra P, Kim M, Shah A, Alaee M, Smyth SA. Occurrence and fate of antibiotic, analgesic/anti-inflammatory, and antifungal compounds in five wastewater treatment processes. Sci Total Environ 2014;473–474:235–43. link1
[47] Kim M, Guerra P, Shah A, Parsa M, Alaee M, Smyth SA. Removal of pharmaceuticals and personal care products in a membrane bioreactor wastewater treatment plant. Water Sci Technol 2014;69(11):2221–9. link1
[48] Sabourin L, Duenk P, Bonte-Gelok S, Payne M, Lapen DR, Topp E. Uptake of pharmaceuticals, hormones and parabens into vegetables grown in soil fertilized with municipal biosolids. Sci Total Environ 2012;431:233–6. link1
[49] Tscharke BJ, Chen C, Gerber JP, White JM. Temporal trends in drug use in Adelaide, South Australia by wastewater analysis. Sci Total Environ 2016;565:384–91. link1
[50] Monsalvo VM. Efficient management of wastewater from manufacturing: new treatment technologies. Boca Raton: CRC Press; 2015. link1
[51] Irvine RJ, Kostakis C, Felgate PD, Jaehne EJ, Chen C, White JM. Population drug use in Australia: a wastewater analysis. Forensic Sci Int 2011;210(1–3):69–73. link1
[52] Subedi B, Kannan K. Mass loading and removal of select illicit drugs in two wastewater treatment plants in New York State and estimation of illicit drug usage in communities through wastewater analysis. Environ Sci Technol 2014;48(12):6661–70. link1
[53] Boleda MAR, Galceran MAT, Ventura F. Monitoring of opiates, cannabinoids and their metabolites in wastewater, surface water and finished water in Catalonia, Spain. Water Res 2009;43(4):1126–36. link1
[54] Kolmonen M, Leinonen A, Kuuranne T, Pelander A, Ojanperä I. Hydrophilic interaction liquid chromatography and accurate mass measurement for quantification and confirmation of morphine, codeine and their glucuronide conjugates in human urine. J Chromatogr B, Anal Technol Biomed Life Sci 2010;878(29):2959–66. link1
[55] Calza P, Vione D. Photodegradation of drugs/illicit drugs in water, in light in forensic science. In: Miolo G, Stair JL, Zloh M, editors. Light in forensic science: issues and applications. Cambridge: Royal Society of Chemistry; 2018. p. 371–98. link1
[56] Yadav MK, Short MD, Aryal R, Gerber C, Van den Akker B, Saint CP. Occurrence of illicit drugs in water and wastewater and their removal during wastewater treatment. Water Res 2017;124:713–27. link1
[57] Pal R, Megharaj M, Kirkbride KP, Heinrich T, Naidu R. Biotic and abiotic degradation of illicit drugs, their precursor, and by-products in soil. Chemosphere 2011;85(6):1002–9. link1
[58] Langford KH, Reid M, Thomas KV. Multi-residue screening of prioritised human pharmaceuticals, illicit drugs and bactericides in sediments and sludge. J Environ Monit 2011;13(8):2284–91. link1
[59] Mastroianni N, López-García E, Postigo C, Barceló D, López de Alda M. Five-year monitoring of 19 illicit and legal substances of abuse at the inlet of a wastewater treatment plant in Barcelona (NE Spain) and estimation of drug consumption patterns and trends. Sci Total Environ 2017;609:916–26. link1
[60] Gago-Ferrero P, Borova V, Dasenaki ME, Thomaidis NS. Simultaneous determination of 148 pharmaceuticals and illicit drugs in sewage sludge based on ultrasound-assisted extraction and liquid chromatography-tandem mass spectrometry. Anal Bioanal Chem 2015;407(15):4287–97. link1
[61] Semblante GU, Hai FI, Huang X, Ball AS, Price WE, Nghiem LD. Trace organic contaminants in biosolids: impact of conventional wastewater and sludge processing technologies and emerging alternatives. J Hazard Mater 2015;300:1–17. link1
[62] Barret M, Delgadillo-Mirquez L, Trably E, Delgenes N, Braun F, Cea-Barcia G, et al. Anaerobic removal of trace organic contaminants in sewage sludge: 15 years of experience. Pedosphere 2012;22(4):508–17. link1
[63] Tscharke BJ, Chen C, Gerber JP, White JM. Trends in stimulant use in Australia: a comparison of wastewater analysis and population surveys. Sci Total Environ 2015;536:331–7. link1
[64] Pal R, Megharaj M, Kirkbride KP, Naidu R. Adsorption and desorption characteristics of methamphetamine, 3,4-methylenedioxymethamphetamine, and pseudoephedrine in soils. Environ Sci Pollut Res Int 2015;22(12):8855–65. link1
[65] Langdon KA. Environmental behaviour of pharmaceuticals, personal care products and endocrine disrupting compounds following land application of biosolids. Adelaide: University of Adelaide; 2010. link1
[66] Van der Aa M, Bijlsma L, Emke E, Dijkman E, Van Nuijs ALN, Van de Ven B, et al. Risk assessment for drugs of abuse in the Dutch watercycle. Water Res 2013;47(5):1848–57. link1
[67] Grung M, Heimstad E, Moe M, Schlabach M, Svenson A, Thomas K, et al. Human and veterinary pharmaceuticals, narcotics, and personal care products in the environment. Current state of knowledge and monitoring requirements. Report. Trondheim: Norwegian Climate and Pollution Agency 2007. Report No.: TA-2325.
[68] Archer E, Petrie B, Kasprzyk-Hordern B, Wolfaardt GM. The fate of pharmaceuticals and personal care products (PPCPs), endocrine disrupting contaminants (EDCs), metabolites and illicit drugs in a WWTW and environmental waters. Chemosphere 2017;174:437–46. link1
[69] Verlicchi P, Al Aukidy M, Zambello E. Occurrence of pharmaceutical compounds in urban wastewater: removal, mass load and environmental risk after a secondary treatment–a review. Sci Total Environ 2012;429:123–55. link1
[70] Brown C, Ellson A, Ledger R, Sorensen G, Cunliffe D, Simon D, et al. DRAFT South Australian biosolids guidelines for the safe handling and reuse of biosolids. South Australia: Environment Protection Authority; 2009. link1
京公网安备 11010502051620号
